Daniel W Curry, Laís F Berro, Andie R Belkoff, Agnieszka Sulima, Kenner C Rice, Leonard L Howell. Neuropharmacology 2019
Times Cited: 4
Times Cited: 4
Times Cited
Times Co-cited
Similarity
MDMA enhances emotional empathy and prosocial behavior.
Cédric M Hysek, Yasmin Schmid, Linda D Simmler, Gregor Domes, Markus Heinrichs, Christoph Eisenegger, Katrin H Preller, Boris B Quednow, Matthias E Liechti. Soc Cogn Affect Neurosci 2014
Cédric M Hysek, Yasmin Schmid, Linda D Simmler, Gregor Domes, Markus Heinrichs, Christoph Eisenegger, Katrin H Preller, Boris B Quednow, Matthias E Liechti. Soc Cogn Affect Neurosci 2014
75
Oxytocin-dependent reopening of a social reward learning critical period with MDMA.
Romain Nardou, Eastman M Lewis, Rebecca Rothhaas, Ran Xu, Aimei Yang, Edward Boyden, Gül Dölen. Nature 2019
Romain Nardou, Eastman M Lewis, Rebecca Rothhaas, Ran Xu, Aimei Yang, Edward Boyden, Gül Dölen. Nature 2019
75
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.
Michael C Mithoefer, Mark T Wagner, Ann T Mithoefer, Lisa Jerome, Scott F Martin, Berra Yazar-Klosinski, Yvonne Michel, Timothy D Brewerton, Rick Doblin. J Psychopharmacol 2013
Michael C Mithoefer, Mark T Wagner, Ann T Mithoefer, Lisa Jerome, Scott F Martin, Berra Yazar-Klosinski, Yvonne Michel, Timothy D Brewerton, Rick Doblin. J Psychopharmacol 2013
75
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.
Alicia L Danforth, Charles S Grob, Christopher Struble, Allison A Feduccia, Nick Walker, Lisa Jerome, Berra Yazar-Klosinski, Amy Emerson. Psychopharmacology (Berl) 2018
Alicia L Danforth, Charles S Grob, Christopher Struble, Allison A Feduccia, Nick Walker, Lisa Jerome, Berra Yazar-Klosinski, Amy Emerson. Psychopharmacology (Berl) 2018
75
Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies.
Matthias E. Liechti, Franz X. Vollenweider. Hum Psychopharmacol 2001
Matthias E. Liechti, Franz X. Vollenweider. Hum Psychopharmacol 2001
75
MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions.
Cédric M Hysek, Gregor Domes, Matthias E Liechti. Psychopharmacology (Berl) 2012
Cédric M Hysek, Gregor Domes, Matthias E Liechti. Psychopharmacology (Berl) 2012
50
The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?
Anya K Bershad, Melissa A Miller, Matthew J Baggott, Harriet de Wit. J Psychopharmacol 2016
Anya K Bershad, Melissa A Miller, Matthew J Baggott, Harriet de Wit. J Psychopharmacol 2016
50
Effects of MDMA on sociability and neural response to social threat and social reward.
Gillinder Bedi, K Luan Phan, Mike Angstadt, Harriet de Wit. Psychopharmacology (Berl) 2009
Gillinder Bedi, K Luan Phan, Mike Angstadt, Harriet de Wit. Psychopharmacology (Berl) 2009
50
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Michael C Mithoefer, Allison A Feduccia, Lisa Jerome, Anne Mithoefer, Mark Wagner, Zach Walsh, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin. Psychopharmacology (Berl) 2019
Michael C Mithoefer, Allison A Feduccia, Lisa Jerome, Anne Mithoefer, Mark Wagner, Zach Walsh, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin. Psychopharmacology (Berl) 2019
50
Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.
G J H Dumont, F C G J Sweep, R van der Steen, R Hermsen, A R T Donders, D J Touw, J M A van Gerven, J K Buitelaar, R J Verkes. Soc Neurosci 2009
G J H Dumont, F C G J Sweep, R van der Steen, R Hermsen, A R T Donders, D J Touw, J M A van Gerven, J K Buitelaar, R J Verkes. Soc Neurosci 2009
50
The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity.
Robin L Carhart-Harris, Kevin Murphy, Robert Leech, David Erritzoe, Matthew B Wall, Bart Ferguson, Luke T J Williams, Leor Roseman, Stefan Brugger, Ineke De Meer,[...]. Biol Psychiatry 2015
Robin L Carhart-Harris, Kevin Murphy, Robert Leech, David Erritzoe, Matthew B Wall, Bart Ferguson, Luke T J Williams, Leor Roseman, Stefan Brugger, Ineke De Meer,[...]. Biol Psychiatry 2015
50
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.
Ronald C Kessler, Patricia Berglund, Olga Demler, Robert Jin, Kathleen R Merikangas, Ellen E Walters. Arch Gen Psychiatry 2005
Ronald C Kessler, Patricia Berglund, Olga Demler, Robert Jin, Kathleen R Merikangas, Ellen E Walters. Arch Gen Psychiatry 2005
50
MDMA decreases the effects of simulated social rejection.
Charles G Frye, Margaret C Wardle, Greg J Norman, Harriet de Wit. Pharmacol Biochem Behav 2014
Charles G Frye, Margaret C Wardle, Greg J Norman, Harriet de Wit. Pharmacol Biochem Behav 2014
50
Gender differences in the subjective effects of MDMA.
M E Liechti, A Gamma, F X Vollenweider. Psychopharmacology (Berl) 2001
M E Liechti, A Gamma, F X Vollenweider. Psychopharmacology (Berl) 2001
50
MDMA effects consistent across laboratories.
Matthew G Kirkpatrick, Matthew J Baggott, John E Mendelson, Gantt P Galloway, Matthias E Liechti, Cédric M Hysek, Harriet de Wit. Psychopharmacology (Berl) 2014
Matthew G Kirkpatrick, Matthew J Baggott, John E Mendelson, Gantt P Galloway, Matthias E Liechti, Cédric M Hysek, Harriet de Wit. Psychopharmacology (Berl) 2014
50
3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans.
A Gamma, A Buck, T Berthold, M E Liechti, F X Vollenweider. Neuropsychopharmacology 2000
A Gamma, A Buck, T Berthold, M E Liechti, F X Vollenweider. Neuropsychopharmacology 2000
50
Neural correlates of MDMA ("Ecstasy")-induced social interaction in rats.
M R Thompson, G E Hunt, I S McGregor. Soc Neurosci 2009
M R Thompson, G E Hunt, I S McGregor. Soc Neurosci 2009
50
Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects.
Patrick C Dolder, Felix Müller, Yasmin Schmid, Stefan J Borgwardt, Matthias E Liechti. Psychopharmacology (Berl) 2018
Patrick C Dolder, Felix Müller, Yasmin Schmid, Stefan J Borgwardt, Matthias E Liechti. Psychopharmacology (Berl) 2018
50
A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).
Peter Oehen, Rafael Traber, Verena Widmer, Ulrich Schnyder. J Psychopharmacol 2013
Peter Oehen, Rafael Traber, Verena Widmer, Ulrich Schnyder. J Psychopharmacol 2013
50
The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.
Philip Kamilar-Britt, Gillinder Bedi. Neurosci Biobehav Rev 2015
Philip Kamilar-Britt, Gillinder Bedi. Neurosci Biobehav Rev 2015
50
MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults.
Alicia L Danforth, Christopher M Struble, Berra Yazar-Klosinski, Charles S Grob. Prog Neuropsychopharmacol Biol Psychiatry 2016
Alicia L Danforth, Christopher M Struble, Berra Yazar-Klosinski, Charles S Grob. Prog Neuropsychopharmacol Biol Psychiatry 2016
50
Distinct neural mechanisms for the prosocial and rewarding properties of MDMA.
Boris D Heifets, Juliana S Salgado, Madison D Taylor, Paul Hoerbelt, Daniel F Cardozo Pinto, Elizabeth E Steinberg, Jessica J Walsh, Ji Y Sze, Robert C Malenka. Sci Transl Med 2019
Boris D Heifets, Juliana S Salgado, Madison D Taylor, Paul Hoerbelt, Daniel F Cardozo Pinto, Elizabeth E Steinberg, Jessica J Walsh, Ji Y Sze, Robert C Malenka. Sci Transl Med 2019
50
Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting.
Matthew J Baggott, Jeremy R Coyle, Jennifer D Siegrist, Kathleen J Garrison, Gantt P Galloway, John E Mendelson. J Psychopharmacol 2016
Matthew J Baggott, Jeremy R Coyle, Jennifer D Siegrist, Kathleen J Garrison, Gantt P Galloway, John E Mendelson. J Psychopharmacol 2016
50
Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects.
Linda D Simmler, Cédric M Hysek, Matthias E Liechti. J Clin Endocrinol Metab 2011
Linda D Simmler, Cédric M Hysek, Matthias E Liechti. J Clin Endocrinol Metab 2011
25
Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care.
Charles W Hoge, Carl A Castro, Stephen C Messer, Dennis McGurk, Dave I Cotting, Robert L Koffman. N Engl J Med 2004
Charles W Hoge, Carl A Castro, Stephen C Messer, Dennis McGurk, Dave I Cotting, Robert L Koffman. N Engl J Med 2004
25
Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review.
Giovanni A Fava, Alessia Gatti, Carlotta Belaise, Jenny Guidi, Emanuela Offidani. Psychother Psychosom 2015
Giovanni A Fava, Alessia Gatti, Carlotta Belaise, Jenny Guidi, Emanuela Offidani. Psychother Psychosom 2015
25
Comparative Efficacy and Acceptability of Pharmacological, Psychotherapeutic, and Combination Treatments in Adults With Posttraumatic Stress Disorder: A Network Meta-analysis.
Jasmin Merz, Guido Schwarzer, Heike Gerger. JAMA Psychiatry 2019
Jasmin Merz, Guido Schwarzer, Heike Gerger. JAMA Psychiatry 2019
25
Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
Thelma Schilt, Maartje M L de Win, Maarten Koeter, Gerry Jager, Dirk J Korf, Wim van den Brink, Ben Schmand. Arch Gen Psychiatry 2007
Thelma Schilt, Maartje M L de Win, Maarten Koeter, Gerry Jager, Dirk J Korf, Wim van den Brink, Ben Schmand. Arch Gen Psychiatry 2007
25
Understanding factors associated with early therapeutic alliance in PTSD treatment: adherence, childhood sexual abuse history, and social support.
Stephanie M Keller, Lori A Zoellner, Norah C Feeny. J Consult Clin Psychol 2010
Stephanie M Keller, Lori A Zoellner, Norah C Feeny. J Consult Clin Psychol 2010
25
A Systematic Review of Dropout From Psychotherapy for Posttraumatic Stress Disorder Among Iraq and Afghanistan Combat Veterans.
Elizabeth M Goetter, Eric Bui, Rebecca A Ojserkis, Rebecca J Zakarian, Rebecca Weintraub Brendel, Naomi M Simon. J Trauma Stress 2015
Elizabeth M Goetter, Eric Bui, Rebecca A Ojserkis, Rebecca J Zakarian, Rebecca Weintraub Brendel, Naomi M Simon. J Trauma Stress 2015
25
MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
Allison A Feduccia, Michael C Mithoefer. Prog Neuropsychopharmacol Biol Psychiatry 2018
Allison A Feduccia, Michael C Mithoefer. Prog Neuropsychopharmacol Biol Psychiatry 2018
25
Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis.
Andrea Cipriani, Taryn Williams, Adriani Nikolakopoulou, Georgia Salanti, Anna Chaimani, Jonathan Ipser, Phil J Cowen, John R Geddes, Dan J Stein. Psychol Med 2018
Andrea Cipriani, Taryn Williams, Adriani Nikolakopoulou, Georgia Salanti, Anna Chaimani, Jonathan Ipser, Phil J Cowen, John R Geddes, Dan J Stein. Psychol Med 2018
25
Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations.
C S Grob, R E Poland, L Chang, T Ernst. Behav Brain Res 1996
C S Grob, R E Poland, L Chang, T Ernst. Behav Brain Res 1996
25
Psychedelics Promote Structural and Functional Neural Plasticity.
Calvin Ly, Alexandra C Greb, Lindsay P Cameron, Jonathan M Wong, Eden V Barragan, Paige C Wilson, Kyle F Burbach, Sina Soltanzadeh Zarandi, Alexander Sood, Michael R Paddy,[...]. Cell Rep 2018
Calvin Ly, Alexandra C Greb, Lindsay P Cameron, Jonathan M Wong, Eden V Barragan, Paige C Wilson, Kyle F Burbach, Sina Soltanzadeh Zarandi, Alexander Sood, Michael R Paddy,[...]. Cell Rep 2018
25
Safety pharmacology of acute MDMA administration in healthy subjects.
Patrick Vizeli, Matthias E Liechti. J Psychopharmacol 2017
Patrick Vizeli, Matthias E Liechti. J Psychopharmacol 2017
25
2015 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 33rd Annual Report.
James B Mowry, Daniel A Spyker, Daniel E Brooks, Ashlea Zimmerman, Jay L Schauben. Clin Toxicol (Phila) 2016
James B Mowry, Daniel A Spyker, Daniel E Brooks, Ashlea Zimmerman, Jay L Schauben. Clin Toxicol (Phila) 2016
25
The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories.
R L Carhart-Harris, M B Wall, D Erritzoe, M Kaelen, B Ferguson, I De Meer, M Tanner, M Bloomfield, T M Williams, M Bolstridge,[...]. Int J Neuropsychopharmacol 2014
R L Carhart-Harris, M B Wall, D Erritzoe, M Kaelen, B Ferguson, I De Meer, M Tanner, M Bloomfield, T M Williams, M Bolstridge,[...]. Int J Neuropsychopharmacol 2014
25
Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
Mark T Wagner, Michael C Mithoefer, Ann T Mithoefer, Rebecca K MacAulay, Lisa Jerome, Berra Yazar-Klosinski, Rick Doblin. J Psychopharmacol 2017
Mark T Wagner, Michael C Mithoefer, Ann T Mithoefer, Rebecca K MacAulay, Lisa Jerome, Berra Yazar-Klosinski, Rick Doblin. J Psychopharmacol 2017
25
Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.
Robert H Pietrzak, Risë B Goldstein, Steven M Southwick, Bridget F Grant. J Anxiety Disord 2011
Robert H Pietrzak, Risë B Goldstein, Steven M Southwick, Bridget F Grant. J Anxiety Disord 2011
25
Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study.
Gerry Jager, Maartje M de Win, Hylke K Vervaeke, Thelma Schilt, Rene S Kahn, Wim van den Brink, Jan M van Ree, Nick F Ramsey. Psychopharmacology (Berl) 2007
Gerry Jager, Maartje M de Win, Hylke K Vervaeke, Thelma Schilt, Rene S Kahn, Wim van den Brink, Jan M van Ree, Nick F Ramsey. Psychopharmacology (Berl) 2007
25
Posttraumatic Stress Disorder-Related Hospitalizations in the United States (2002-2011): Rates, Co-Occurring Illnesses, Suicidal Ideation/Self-Harm, and Hospital Charges.
Mark G Haviland, Jim E Banta, Janet L Sonne, Peter Przekop. J Nerv Ment Dis 2016
Mark G Haviland, Jim E Banta, Janet L Sonne, Peter Przekop. J Nerv Ment Dis 2016
25
Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder.
J R Davidson, B O Rothbaum, B A van der Kolk, C R Sikes, G M Farfel. Arch Gen Psychiatry 2001
J R Davidson, B O Rothbaum, B A van der Kolk, C R Sikes, G M Farfel. Arch Gen Psychiatry 2001
25
Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective.
Kim P C Kuypers, Eef L Theunissen, Janelle H P van Wel, Elizabeth B de Sousa Fernandes Perna, Anke Linssen, Anke Sambeth, Benjamin G Schultz, Johannes G Ramaekers. PLoS One 2016
Kim P C Kuypers, Eef L Theunissen, Janelle H P van Wel, Elizabeth B de Sousa Fernandes Perna, Anke Linssen, Anke Sambeth, Benjamin G Schultz, Johannes G Ramaekers. PLoS One 2016
25
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA.
Michael C Mithoefer, Charles S Grob, Timothy D Brewerton. Lancet Psychiatry 2016
Michael C Mithoefer, Charles S Grob, Timothy D Brewerton. Lancet Psychiatry 2016
25
Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
K Brady, T Pearlstein, G M Asnis, D Baker, B Rothbaum, C R Sikes, G M Farfel. JAMA 2000
K Brady, T Pearlstein, G M Asnis, D Baker, B Rothbaum, C R Sikes, G M Farfel. JAMA 2000
25
Are ecstasy induced serotonergic alterations overestimated for the majority of users?
Balázs Szigeti, Adam R Winstock, David Erritzoe, Larissa J Maier. J Psychopharmacol 2018
Balázs Szigeti, Adam R Winstock, David Erritzoe, Larissa J Maier. J Psychopharmacol 2018
25
Progress and promise for the MDMA drug development program.
Allison A Feduccia, Julie Holland, Michael C Mithoefer. Psychopharmacology (Berl) 2018
Allison A Feduccia, Julie Holland, Michael C Mithoefer. Psychopharmacology (Berl) 2018
25
A meta-analytic review of prolonged exposure for posttraumatic stress disorder.
Mark B Powers, Jacqueline M Halpern, Michael P Ferenschak, Seth J Gillihan, Edna B Foa. Clin Psychol Rev 2010
Mark B Powers, Jacqueline M Halpern, Michael P Ferenschak, Seth J Gillihan, Edna B Foa. Clin Psychol Rev 2010
25
Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis.
Mathew Hoskins, Jennifer Pearce, Andrew Bethell, Liliya Dankova, Corrado Barbui, Wietse A Tol, Mark van Ommeren, Joop de Jong, Soraya Seedat, Hanhui Chen,[...]. Br J Psychiatry 2015
Mathew Hoskins, Jennifer Pearce, Andrew Bethell, Liliya Dankova, Corrado Barbui, Wietse A Tol, Mark van Ommeren, Joop de Jong, Soraya Seedat, Hanhui Chen,[...]. Br J Psychiatry 2015
25
The spurious relationship between ecstasy use and neurocognitive deficits: A Bradford Hill review.
Timothy Amoroso. Int J Drug Policy 2019
Timothy Amoroso. Int J Drug Policy 2019
25
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.